- Home
- Search Results
- Page 1 of 1
Search for: All records
-
Total Resources2
- Resource Type
-
0000000002000000
- More
- Availability
-
11
- Author / Contributor
- Filter by Author / Creator
-
-
Brenner, Jacob S (2)
-
Brysgel, Taylor V (2)
-
Hood, Elizabeth D (2)
-
Muzykantov, Vladimir R (2)
-
Myerson, Jacob W (2)
-
Nong, Jia (2)
-
Shuvaev, Vladimir V (2)
-
Weissman, Drew (2)
-
Alameh, Mohamad-Gabriel (1)
-
Arguiri, Evguenia (1)
-
Atluri, Pavan (1)
-
Eaton, Deborah M (1)
-
Ferrari, Victor A (1)
-
Glassman, Patrick M (1)
-
Herbst, Alan (1)
-
Kegel, Michael (1)
-
Kiseleva, Raisa Yu (1)
-
Lee, Benjamin W (1)
-
Marcos-Contreras, Oscar A (1)
-
Margulies, Kenneth B (1)
-
- Filter by Editor
-
-
& Spizer, S. M. (0)
-
& . Spizer, S. (0)
-
& Ahn, J. (0)
-
& Bateiha, S. (0)
-
& Bosch, N. (0)
-
& Brennan K. (0)
-
& Brennan, K. (0)
-
& Chen, B. (0)
-
& Chen, Bodong (0)
-
& Drown, S. (0)
-
& Ferretti, F. (0)
-
& Higgins, A. (0)
-
& J. Peters (0)
-
& Kali, Y. (0)
-
& Ruiz-Arias, P.M. (0)
-
& S. Spitzer (0)
-
& Sahin. I. (0)
-
& Spitzer, S. (0)
-
& Spitzer, S.M. (0)
-
&, John Wiley (0)
-
-
Have feedback or suggestions for a way to improve these results?
!
Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher.
Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?
Some links on this page may take you to non-federal websites. Their policies may differ from this site.
-
Free, publicly-accessible full text available February 20, 2027
-
Shuvaev, Vladimir V; Tam, Ying K; Lee, Benjamin W; Myerson, Jacob W; Herbst, Alan; Kiseleva, Raisa Yu; Glassman, Patrick M; Parhiz, Hamideh; Alameh, Mohamad-Gabriel; Pardi, Norbert; et al (, Proceedings of the National Academy of Sciences)Lipid nanoparticles (LNP) represent a versatile platform for improving delivery of therapeutic nucleic acids. Yet, delivery to the myocardium remains a formidable challenge due to local barriers in the heart and systemic hindrances. In particular, plasma apolipoprotein E (apoE) directs LNP to the liver, limiting potential extrahepatic delivery. Here, we report a cardiotropic LNP (cLNP), which within 30 min post–intravenous injection accumulates in the heart of ApoE knockout (Apoe−/−) mice. The findings were confirmed forApoe−/−rats and for wild-type mice after siRNA-mediated plasma apoE ablation. To test cardiac-specific functional effects as a proof of concept, we used cLNP loaded with siRNA toATP2A2,encoding the sarcoplasmic-endoplasmic reticulum Ca2+ATPase 2a (SERCA2A). This cardiomyocyte-specific protein is a key regulator of contractility and relaxation. Intravenous administration of cLNP/siRNA-ATP2A2 inApoe−/−mice led to near-complete ablation of SERCA2A in the myocardium and a potent modulation of contractility of the cardiomyocytes obtained from these mice. In summary, cardiotropic nanocarriers may allow the delivery and effect of RNA and other agents to the myocardium. Achieving this unmet medical need promises new types of treatment for heart diseases, which remains the leading cause of death worldwide.more » « less
An official website of the United States government
